| Daniel Lawrence Pablo, MD | |
|
100 S Bliss Ave, Tahlequah, OK 74464-2512 | |
| (918) 458-3360 | |
| (918) 458-3511 |
| Full Name | Daniel Lawrence Pablo |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 30 Years |
| Location | 100 S Bliss Ave, Tahlequah, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558449116 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 21445 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Claremore Indian Hospital | Claremore, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Claremore Indian Hospital | 9436069911 | 109 |
News Archive
Scientists at the Innovative Genomics Institute have concocted a transformative new way to harness the power of evolution.
The organisation in the UK which regulates drugs and treatments, the Medicines and Healthcare Products Regulatory Agency (MHRA) is to hold a seminar in London as part of a campaign to improve women's health.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).
Lung transplant patients who took part in a three-month structured exercise program when they were discharged from hospital improved their health-related quality of life and reduced their risk of cardiovascular problems.
A landmark research portal that includes health and biological data from 300,000 Canadians — nearly one in every 50 individuals between the ages of 35 and 69 – is being launched today by the Canadian Partnership Against Cancer (the Partnership).
› Verified 7 days ago
| Entity Name | Cherokee Nation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780692723 PECOS PAC ID: 5799698742 Enrollment ID: O20031106000628 |
News Archive
Scientists at the Innovative Genomics Institute have concocted a transformative new way to harness the power of evolution.
The organisation in the UK which regulates drugs and treatments, the Medicines and Healthcare Products Regulatory Agency (MHRA) is to hold a seminar in London as part of a campaign to improve women's health.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).
Lung transplant patients who took part in a three-month structured exercise program when they were discharged from hospital improved their health-related quality of life and reduced their risk of cardiovascular problems.
A landmark research portal that includes health and biological data from 300,000 Canadians — nearly one in every 50 individuals between the ages of 35 and 69 – is being launched today by the Canadian Partnership Against Cancer (the Partnership).
› Verified 7 days ago
| Entity Name | Claremore Indian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073527842 PECOS PAC ID: 9436069911 Enrollment ID: O20031210001104 |
News Archive
Scientists at the Innovative Genomics Institute have concocted a transformative new way to harness the power of evolution.
The organisation in the UK which regulates drugs and treatments, the Medicines and Healthcare Products Regulatory Agency (MHRA) is to hold a seminar in London as part of a campaign to improve women's health.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).
Lung transplant patients who took part in a three-month structured exercise program when they were discharged from hospital improved their health-related quality of life and reduced their risk of cardiovascular problems.
A landmark research portal that includes health and biological data from 300,000 Canadians — nearly one in every 50 individuals between the ages of 35 and 69 – is being launched today by the Canadian Partnership Against Cancer (the Partnership).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Lawrence Pablo, MD 100 S Bliss Ave, Tahlequah, OK 74464-2512 Ph: (918) 458-3360 | Daniel Lawrence Pablo, MD 100 S Bliss Ave, Tahlequah, OK 74464-2512 Ph: (918) 458-3360 |
News Archive
Scientists at the Innovative Genomics Institute have concocted a transformative new way to harness the power of evolution.
The organisation in the UK which regulates drugs and treatments, the Medicines and Healthcare Products Regulatory Agency (MHRA) is to hold a seminar in London as part of a campaign to improve women's health.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).
Lung transplant patients who took part in a three-month structured exercise program when they were discharged from hospital improved their health-related quality of life and reduced their risk of cardiovascular problems.
A landmark research portal that includes health and biological data from 300,000 Canadians — nearly one in every 50 individuals between the ages of 35 and 69 – is being launched today by the Canadian Partnership Against Cancer (the Partnership).
› Verified 7 days ago
Joel Acopio Malabrigo, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 Fax: 918-458-3511 | |
David James Wilson, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 Fax: 918-458-3511 | |
Dr. David Brent Rotton, DO, FACOS Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E. Downing, #103, Tahlequah, OK 74464 Phone: 918-207-1140 Fax: 918-207-0335 | |
Mohamed Yousef Elsagga, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 Fax: 918-458-3610 | |
James W Smith, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 E Downing St, Tahlequah, OK 74464 Phone: 918-456-0641 | |
Dr. Dustin Ryan Beck, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 S. Bliss Ave., Tahlequah, OK 74464 Phone: 918-458-3100 |